piracetam has been researched along with Fukuhara Disease in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Excerpt | Relevance | Reference |
---|---|---|
"Levetiracetam (LEV) treatment was started in combination with VPA in a patient with typical clinical, histological, and biochemical features of MERRF due to a mutation on the tRNA of Phenilalanine gene." | 1.33 | Antimyoclonic effect of levetiracetam in MERRF syndrome. ( Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crest, C | 1 |
Dupont, S | 1 |
Leguern, E | 1 |
Adam, C | 1 |
Baulac, M | 1 |
Mancuso, M | 2 |
Galli, R | 1 |
Pizzanelli, C | 1 |
Filosto, M | 2 |
Siciliano, G | 2 |
Murri, L | 1 |
Petrozzi, L | 1 |
Nesti, C | 1 |
Rocchi, A | 1 |
Choub, A | 1 |
Pistolesi, S | 1 |
Massetani, R | 1 |
Fontanini, G | 1 |
3 other studies available for piracetam and Fukuhara Disease
Article | Year |
---|---|
Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.
Topics: Activities of Daily Living; Adolescent; Anticonvulsants; Child; Drug Evaluation; Drug Therapy, Combi | 2004 |
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Gene | 2006 |
MERRF syndrome without ragged-red fibers: the need for molecular diagnosis.
Topics: Adolescent; Adult; Child; Humans; Levetiracetam; Male; MERRF Syndrome; Muscle Fibers, Fast-Twitch; P | 2007 |